Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Curevo Vaccine announces closing of $26m Series A1 round
Clinical-stage biotechnology company Curevo Vaccine has announced the closing of $26m Series A1 financing round.
Dermatology
-
17 Nov 2022
-
16 Jun 2022
Quoin Pharmaceuticals signs license, distribution agreement with WinHealth Pharma
Quoin Pharmaceuticals has signed a license and distribution agreement with Hong Kong WinHealth Pharma Group for its lead product candidate, QRX003 for Netherton Syndrome and a second pipeline product, QRX004 for Epidermolysis Bullosa.
-
02 Dec 2021
Sanofi agrees to buy Austria-based Origimm Biotechnology
Sanofi has signed an agreement to buy Origimm Biotechnology, an Austria-based privately owned biotechnology company with focus on virulent skin microbiome components and antigens from bacteria causing skin disease.
-
08 Apr 2021
AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis
AbbVie has submitted applications seeking approval for SKYRIZI (risankizumab-rzaa, 150 mg) and SKYRIZI (risankizumab, 150 mg) to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), respectively, for the treatment of adults with active psoriatic arthritis.